145 related articles for article (PubMed ID: 8898925)
1. Mobilization and collection of PBSC in healthy donors: comparison between two schemes of rhG-CSF administration.
Majolino I; Scimé R; Vasta S; Cavallaro AM; Fiandaca T; Indovina A; Catania P; Santoro A
Eur J Haematol; 1996 Sep; 57(3):214-21. PubMed ID: 8898925
[TBL] [Abstract][Full Text] [Related]
2. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
3. Treatment of normal donors with rhG-CSF 16 micrograms/kg for mobilization of peripheral blood stem cells and their apheretic collection for allogeneic transplantation.
Majolino I; Buscemi F; Scimé R; Indovina A; Santoro A; Vasta S; Pampinella M; Catania P; Fiandaca T; Caronia F
Haematologica; 1995; 80(3):219-26. PubMed ID: 7545635
[TBL] [Abstract][Full Text] [Related]
4. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
Gómez-Espuch J; Moraleda JM; Ortuño F; Lozano ML; Ayala F; Vallejo C; de Arriba F; Vicente V
Bone Marrow Transplant; 2000 Feb; 25(3):231-5. PubMed ID: 10673692
[TBL] [Abstract][Full Text] [Related]
6. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
J Clin Apher; 2001; 16(2):82-7. PubMed ID: 11746533
[TBL] [Abstract][Full Text] [Related]
7. Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation.
Engelhardt M; Bertz H; Wäsch R; Finke J
Ann Hematol; 2001 Apr; 80(4):201-8. PubMed ID: 11401085
[TBL] [Abstract][Full Text] [Related]
8. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
[TBL] [Abstract][Full Text] [Related]
9. [Factors affecting mobilization of peripheral blood stem/progenitor cells and apheresis efficiency from healthy donors by rhG-CSF].
Liang ZY; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):847-51. PubMed ID: 18718074
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
[TBL] [Abstract][Full Text] [Related]
11. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO).
Majolino I; Cavallaro AM; Bacigalupo A; Rambaldi A; Falda M; Locatelli F; Raimondi R; Pucci G; Mordini N; Barbui T; Locatelli F; Rodeghiero F; Irrera G; Indovina A; Valbonesi M; Bellavita P; Tassi V; Perotti C; Soli M; Bresolin G
Haematologica; 1997; 82(1):47-52. PubMed ID: 9107082
[TBL] [Abstract][Full Text] [Related]
12. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
[TBL] [Abstract][Full Text] [Related]
13. Sequential changes in stem cell markers in peripheral blood and leukapheresis samples after injections of recombinant human granulocyte colony-stimulating factor in patients with urogenital malignant solid tumors: a preliminary study.
Samma S; Momose H; Ozono S; Hirao Y; Okajima E; Morii T; Nishikawa K; Shimoyama T; Fujimura Y
Jpn J Clin Oncol; 1994 Oct; 24(5):269-74. PubMed ID: 7526017
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
[TBL] [Abstract][Full Text] [Related]
15. rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes.
Sica S; Rutella S; Di Mario A; Salutari P; Rumi C; Ortu la Barbera E; Etuk B; Menichella G; D'Onofrio G; Leone G
J Hematother; 1996 Aug; 5(4):391-7. PubMed ID: 8877714
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic blood stem cell transplantation: considerations for donors.
Anderlini P; Körbling M; Dale D; Gratwohl A; Schmitz N; Stroncek D; Howe C; Leitman S; Horowitz M; Gluckman E; Rowley S; Przepiorka D; Champlin R
Blood; 1997 Aug; 90(3):903-8. PubMed ID: 9242518
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen.
Waller CF; Bertz H; Wenger MK; Fetscher S; Hardung M; Engelhardt M; Behringer D; Lange W; Mertelsmann R; Finke J
Bone Marrow Transplant; 1996 Aug; 18(2):279-83. PubMed ID: 8864435
[TBL] [Abstract][Full Text] [Related]
19. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
[TBL] [Abstract][Full Text] [Related]
20. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]